American Cancer Society Funds Life-Saving Work by Switching to Rimini Street

Go back to American Cancer Society Funds Life-Saving Work by Switching to Rimini Street

UBS Reiterates Buy on Oracle (ORCL) Following Field Checks

September 15, 2015 8:43 AM EDT

UBS reiterated a Buy rating and $46.00 price target on Oracle (NYSE: ORCL) following field checks. A global survey of 50 ORCL value-added resellers yielded okay results, with a majority seeing fair q/q sales trends and coming in line with forecasted targets.

Analyst Brent Thill... More